Literature DB >> 2873886

Immunosuppressive factors from adult T-cell leukemia cells.

F Shirakawa, Y Tanaka, S Oda, S Chiba, H Suzuki, S Eto, U Yamashita.   

Abstract

The mechanism of immunodeficiency in adult T-cell leukemia (ATL) patients was studied in vitro. Peripheral blood lymphocytes from ATL patients and ATL cell lines such as Hut 102, MT 1, and MT 2 were not activated to proliferate by the stimulation with concanavalin A and suppressed normal lymphocyte proliferative responses induced with concanavalin A when cultured together. The sera from ATL patients and the culture supernatants from ATL cells and ATL cell lines also suppressed normal lymphocyte proliferative responses induced with concanavalin A. By Sephacryl S-200 column chromatography, the suppressive factors were fractionated as a single peak with the molecular weights of 50,000 to 70,000. The suppressive factors were unstable to acid treatment but stable to the treatment with base, heat, freezing-thawing, and trypsin. The factors suppressed the production of interleukin 2 by T-cells and the responsiveness of T-cells to interleukin 2, but not the expression of interleukin 2 receptors on T-cells and the production of interleukin 1 by monocytes. These results suggest that the immunosuppressive factors produced by ATL cells have some roles in the induction of immunodeficient states in ATL patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873886

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

2.  Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Authors:  Andrea K Kress; Grit Schneider; Klemens Pichler; Martina Kalmer; Bernhard Fleckenstein; Ralph Grassmann
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

3.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

4.  Serum suppressive activity of HIV seropositive patients.

Authors:  D Israel-Biet; M Ekwalanga; A Venet; P Even; J M Andrieu
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.

Authors:  S J Kim; J H Kehrl; J Burton; C L Tendler; K T Jeang; D Danielpour; C Thevenin; K Y Kim; M B Sporn; A B Roberts
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

6.  Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.

Authors:  T Ikeda; T Masuno; T Ogura; M Watanabe; T Shirasaka; H Hara; Y Tanio; I Kawase; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1991-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.